Trial intelligence / Profile preview

TIVA vs Balanced Anesthesia in Diabetic Patients Undergoing VATS

NCT07496593Phase 4Active, not recruiting

Sponsor
Ain Shams University
Start
Dec 2025
Primary completion
Dec 2026
Modality
Allosteric Modulators
Countries
1
01

Overview

Phase 4, randomised, open-label trial of propofol and isoflurane (2 arms), sponsored by Ain Shams University. Primary endpoint: Blood glucose level at 1.5 hours. Started Dec 2025; status: active, not recruiting.

02

Drugs

propofolisoflurane

Beyond the preview

Go deeper on NCT07496593.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07496593.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call